Fox COBRE Phase II Admin Core

Fox COBRE 第二阶段管理核心

基本信息

  • 批准号:
    10654735
  • 负责人:
  • 金额:
    $ 149.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary Administrative Core This Phase II COBRE will continue our center’s work to develop molecular approaches for probing biology, to discover and apply new chemical biology tools for the study of biological pathways associated with disease, and to develop computational approaches for understanding small molecule interactions with complex macromolecular targets. Building on the infrastructure and successes of Phase I, our COBRE will develop new chemical biology tools for understanding the cellular and molecular mechanisms that bacterial pathogens use to survive and replicate inside host cells, molecular probes that can be used to understand Clp protease targets of infectious diseases, tools to map and understand the regulation of reversible mRNA modification by a ‘methyl eraser’ enzyme linked to the progression of human cancers, molecularly-defined nanoparticle adjuvants that yield specific immune responses in the lung to advance inhalable vaccine development, and computational approaches to elucidate the mechanisms by which small molecules regulate the structure and function of virus capsids. The goals of the Administrative Core are (1) Development of the administrative, fiscal and scientific aspects of the proposed COBRE, including establishment of a leadership team and a hiring plan; (2) Implementation of summative and formative evaluation strategies by the Leadership Team, an Internal Advisory Committee (IAC), mentors, and an External Advisory Committee (EAC); (3) Implementation of a Career Guidance Plan that enables faculty to develop successful research programs and to attract funding for their work; (4) Development of research, training & career development goals and capabilities. A plan for hiring and retaining successful faculty is detailed as is a plan for transitioning investigators to independent status with continued access to core facilities and participation in COBRE sponsored events.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH M FOX其他文献

JOSEPH M FOX的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH M FOX', 18)}}的其他基金

Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
  • 批准号:
    9899272
  • 财政年份:
    2019
  • 资助金额:
    $ 149.82万
  • 项目类别:
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
  • 批准号:
    10660115
  • 财政年份:
    2019
  • 资助金额:
    $ 149.82万
  • 项目类别:
NIH ADMINISTRATIVE SUPPLEMENT FPLC SYSTEM FOX
NIH 行政补充 FPLC 系统 FOX
  • 批准号:
    9925864
  • 财政年份:
    2019
  • 资助金额:
    $ 149.82万
  • 项目类别:
Supplement to Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包的补充
  • 批准号:
    10046448
  • 财政年份:
    2019
  • 资助金额:
    $ 149.82万
  • 项目类别:
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
  • 批准号:
    10343710
  • 财政年份:
    2019
  • 资助金额:
    $ 149.82万
  • 项目类别:
Discovery of Molecular Probes and Therapeutic Leads, Administrative Supplement for Equipment
分子探针和治疗先导物的发现,设备管理补充
  • 批准号:
    10400299
  • 财政年份:
    2014
  • 资助金额:
    $ 149.82万
  • 项目类别:
Discovery of Chemical Probes and Therapeutic Leads, Phase 2
化学探针和治疗先导化合物的发现,第二阶段
  • 批准号:
    10853967
  • 财政年份:
    2014
  • 资助金额:
    $ 149.82万
  • 项目类别:
Fox COBRE Phase II Admin Core
Fox COBRE 第二阶段管理核心
  • 批准号:
    10026269
  • 财政年份:
    2014
  • 资助金额:
    $ 149.82万
  • 项目类别:
Discovery of Chemical Probes and Therapeutic Leads, Phase II
化学探针和治疗先导化合物的发现,第二阶段
  • 批准号:
    10654734
  • 财政年份:
    2014
  • 资助金额:
    $ 149.82万
  • 项目类别:
Discovery of Chemical Probes and Therapeutic Leads: Cryoprobe Upgrade of a 400 MHz NMR
化学探针和治疗先导化合物的发现:400 MHz NMR 的冷冻探针升级
  • 批准号:
    10581950
  • 财政年份:
    2014
  • 资助金额:
    $ 149.82万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
    Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 149.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了